Primary efficacy in the second interim analysis demonstrates COVAXIN to be 78% effective after the second dose in preventing COVID-19 in those without prior infection
Demonstrates 70% efficacy against asymptomatic COVID-19 infections; indicates potential to significantly reduce virus transmission
COVAXIN has been administered to several million people in India and is playing a critical role in combating the pandemic
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.